Clinical trials - Press Releases

Date	Title	Company
21-Dec-2020	BioMedion AG Announces the Acquisition of the Compliance Division of arivis AG	BioMedion AG
21-Dec-2020	Baris Erdogan succeeds Ian Rentsch as CEO of Clinerion.	Clinerion Ltd.
21-Dec-2020	Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel	Cytel Inc.
18-Dec-2020	EUSA Pharma Announces First Patient Enrolled in a Randomised Phase 3 Clinical Trial Investigating Siltuximab in Hospitalised Patients with COVID-19- or Another Respiratory Virus Infection-Associated Acute Respiratory Distress Syndrome (ARDS)	EUSA Pharma
17-Dec-2020	Notification of Allowance granted for US patent	ReNeuron Group plc
17-Dec-2020	Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia	Amryt
16-Dec-2020	Exclusive Interview: Julian Bahr, Postdoctoral Fellow at AstraZeneca and speaker at 3D Cell Culture Conference	SMi Group
16-Dec-2020	Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEF	Novartis
16-Dec-2020	Teknova completes FDA notification for room temperature-stable viral transport medium	Teknova
16-Dec-2020	Kantar Announces Agreement for Sale of Health Division to Cerner.	Kantar
16-Dec-2020	PharmiWeb.jobs Welcomes Albion Rye Associates	PharmiWeb.Jobs
15-Dec-2020	ABPI Board announces Kate Brunner QC appointed as new Chair of the PMCPA Appeal Board	ABPI
15-Dec-2020	Sensyne Health launches first digital health product in the U.S.	Sensyne Health
15-Dec-2020	Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proof of concept Phase 2 study in Friedreich´s ataxia	Minoryx
15-Dec-2020	CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes	Sanofi
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	Primary care committed to Covid vaccine programme but needs support	NHS Confederation
15-Dec-2020	Polyphor announces third positive Data Safety Monitoring Board (DSMB) recommendation to continue Phase III balixafortide FORTRESS study without modifications	Polyphor AG
15-Dec-2020	The number of Russians ready to be vaccinated against coronavirus has reached 42%, a FOM poll shows	Russian Direct Investment Fund (RDIF)
15-Dec-2020	Janssen Receives Positive CHMP Opinion for SPRAVATO®▼ (Esketamine Nasal Spray) for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder	Janssen Pharmaceutical Companies of Johnson & Johnson